Back

ASCO Plenary Feb 2023 - ASCO Plenary Series: February 2023

Feb 15 - Feb 15, 2023 | AlexandriaLAUS

LARVOL is not affiliated with ASCO Plenary Series: February 2023 and all trademarks, logos, and brand names are property of their respective owners

Condition
Stage
Treatment
Setting
Biomarker
Trial Name/ID

Showing 1 titles linked to Trials

First report of PhALLCON: A phase 3 study comparing ponatinib (pon) vs imatinib (im) in newly diagnosed patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).